[Corrigendum] Linc01105 acts as an oncogene in the development of neuroblastoma

Mujie Ye1, Jing Ma2, Baihui Liu1

  • 1Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai 201102, P.R. China.

Oncology Reports
|July 28, 2021
PubMed

Insights

This corrigendum corrects errors in Fig. 4A of a previously published Oncology Reports article. The corrected figure displays accurate invasion and migration assay data for control and shRNA2 groups, ensuring data integrity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Context:

  • A previous study published in Oncology Reports investigated cellular invasion and migration.
  • The original article (DOI: 10.3892/or.2019.7257) included data presented in Figure 4A.
  • The study focused on the effects of specific genetic modifications (shRNA2) on cancer cell behavior.

Purpose:

  • To correct inadvertent errors in the presentation of data in Figure 4A.
  • To provide a corrected version of Figure 4, accurately representing invasion and migration assay results.
  • To ensure the scientific record reflects the precise experimental outcomes.

Summary:

  • The authors identified errors in Figure 4A concerning the invasion and migration assay data for 'Control' and 'shRNA2' groups.
  • The same source images were mistakenly used for both groups due to preparation and revision errors.
  • A corrected Figure 4 is provided, displaying the accurate data for these experiments.

Impact:

  • The corrections do not alter the original study's conclusions.
  • Ensures the reliability and reproducibility of the published scientific findings.
  • Maintains the integrity of cancer research data presented in Oncology Reports.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K